Influx Healthtech Limited (NSE:INFLUX)

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Vitamins & Nutrition Products	1.05B	999.65M	760.57M	592.02M
Vitamins & Nutrition Products Growth	4.89%	31.44%	28.47%	-
Total	1.05B	999.65M	760.57M	592.02M
Total Growth	4.89%	31.44%	28.47%	-

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	FY 2022
Period Ending	Mar 31, 2022
Export	190.00K
India	591.83M
Total	592.02M

Source: S&P Global Market Intelligence.